Formation of trans ring-fused compounds by an alkylation-radical cyclization sequence
摘要:
Enolates derived from bicyclic lactones of type 1 (Scheme I) can be alkylated with 2-propynylic halides to give products 2, in which the unsaturated alkyl group is syn to the adjacent ring-fusion hydrogen. Reaction of 2 with sodium phenyl selenide and then with diazomethane produces esters 3, and these give trans ring-fused bicyclic compounds 4 when treated with triphenyltin hydride in the presence of a radical initiator. The bicyclic compounds afford ketones on double-bond cleavage, and the angular ester function can be converted into a methyl group. Similar processes occur if an aldehyde is used in the first step instead of a halide. The methodology is general.
Influence of bicyclic anhydride structure on the outcome of the Castagnoli–Cushman reaction
作者:Oleh K. Smyrnov、Mykhailo I. Adamovskyi、Tetiana V. Druzhenko、Kostiantyn P. Melnykov、Dmitriy M. Volochnyuk、Sergey V. Ryabukhin
DOI:10.1007/s10593-023-03211-0
日期:2023.7
Castagnoli–Cushman reaction was carried out with various fused and bridged bicyclic anhydrides. The influence of the anhydride nature and, specifically, the size of fused anhydride rings on the reaction pathway were investigated. The negative outcome of the reaction in the case of small rings and bridged systems was mechanistically described. The scope and limitations of the procedure involving anhydrides and imines
GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID COMPOUND OR SALT THEREOF
申请人:Glytech, Inc.
公开号:EP2924053A1
公开(公告)日:2015-09-30
[Problem] The purpose is to provide a compound containing a carrier linker moiety and a physiologically active substance moiety or a salt of the compound, wherein a carrier in the carrier linker moiety is biodegradable and is soluble in water.
[Solution] The purpose can be achieved by employing a sugar chain as a carrier and focusing on the structure of a carrier-linker having a specified structure. A compound containing a carrier linker moiety and a physiologically active substance moiety or a salt of the compound is discovered.